Home > Insider Trading > Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc. (RYTM)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2024 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 7th, 2024 - News Transcripts

14 Worst 52-Week High Stocks to Buy According to Short Sellers

The start of the US Federal Reserve cutting cycle ushers a new era in the investment world after one of the longest bull runs.

Keep Reading →

September 20th, 2024 - Hedge Funds News

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q2 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 7th, 2024 - News Transcripts

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-2.35058 EPS, expectations were $-2.12. Rhythm Pharmaceuticals, Inc.

Keep Reading →

May 8th, 2024 - News Transcripts

Jim Cramer Portfolio: 11 Latest Stocks to Buy

In this article, we will take a detailed look at Jim Cramer Portfolio: 11 Latest Stocks to Buy.

Keep Reading →

April 28th, 2024 - Hedge Funds News

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc.

Keep Reading →

February 23rd, 2024 - News Transcripts

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q2 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 2nd, 2023 - News Transcripts

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q1 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

May 4th, 2023 - News Transcripts

Top 5 Growth Stocks in Biotech

Headquartered in Bermuda, Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) is a biopharmaceutical company focusing on therapeutics for debilitating disorders.

Keep Reading →

March 28th, 2023 - News

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Red Cat Holdings Fiscal 2023 Third Quarter Financial Results and Corporate Update Conference Call.

Keep Reading →

March 8th, 2023 - News Transcripts